Table 1.

Demographic and clinical data of patients with idiopathic PD (IPD) and multiple system atrophy (MSA)

PatientAge/sexSymptoms of autonomic failure, yOther neurologic symptoms, yLevodopa/DIH type mg/dH/M ratio
The duration of clinical symptoms is given in years.
DIH = dopa-decarboxylase inhibitor; B = DIH benseradine; C = DIH carbodopa; CS = clinically silent; H/M ratio = heart–mediastinum ratio.
IPD
172 /M311200/50 B1.01
269 /F<14300/75 C1.06
371 /M222500/125 C1.49
461 /FCS3600/150 B1.04
569 /M13350/87.5 C1.02
662 /MCS2400/100 C1.14
770 /F<1<1None1.12
872 /MCS7600/150 B1.06
965 /MCS7450/112.5 B1.11
1086 /M13250/62.5 B0.94
1178 /M<120350/87.5 B1.11
1274 /F420400/100 C1.05
1376 /F49250/62.5 B1.00
1467 /F815300/75 B0.97
1568 /M47400/100 C1.13
MSA
1660 /F13No indication2.72
1769 /M21500/125 B1.78
1856 /F32No indication1.95
1975 /F13No indication1.82
2062 /F<11None1.90